Tema Healthcare AI ETF (NQ:HLTH)

27.67 -0.13 (-0.48%)

Official Closing Price Updated: 4:15 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tema Healthcare AI ETF

< Previous 1 2 3 4 5 6 7 Next >

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 02, 2024

Via Benzinga

Dow Down 100 Points; US Manufacturing PMI Falls In December ↗

January 02, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...

Via Benzinga

Topics Stocks

Cue Health: Q3 Earnings Insights ↗

November 08, 2023

Via Benzinga

Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket ↗

January 02, 2024

Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 11, 2023

Via Benzinga

Cue Health Reports Third Quarter 2023 Financial Results

November 08, 2023

From Cue Health Inc.

Via Business Wire

Cue Health to Announce Third Quarter 2023 Financial Results

October 25, 2023

From Cue Health Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 25, 2023

Via Benzinga

Independent Clinical Study Confirms Cue Health’s COVID-19 Test Is As Accurate As a Lab Test

October 20, 2023

--News Direct--

Via News Direct

Independent Clinical Study Confirms Cue Health's COVID-19 Test Is As Accurate As A Lab Test ↗

October 19, 2023

A new study published in Microbiology Spectrum put Cue Health’s (NASDAQ: HLTH) COVID

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 18, 2023

Via Benzinga

Concerned Stockholders of Cue Health Send Letter to Board

October 06, 2023

From On behalf of Concerned Stockholders of Cue Health

Via Business Wire

Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test

October 04, 2023

From Cue Health

Via Business Wire

Cue Health Adopts Limited-Duration Shareholder Rights Plan

September 21, 2023

From Cue Health Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 31, 2023

Via Benzinga

Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 31, 2023

Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 24, 2023

Via Benzinga

Cue Health to Present at Upcoming Investor Conferences

August 23, 2023

From Cue Health Inc.

Via Business Wire

This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test

August 18, 2023

--News Direct--

Via News Direct

This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test ↗

August 17, 2023

The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S.

Via Benzinga

Cue Health Reports Second Quarter 2023 Financial Results

August 09, 2023

From Cue Health Inc.

Via Business Wire

Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

August 03, 2023

From Cue Health Inc.

Via Business Wire

Cue Health to Announce Second Quarter 2023 Financial Results

July 26, 2023

From Cue Health Inc.

Via Business Wire

Cue Health’s Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered

July 25, 2023

--News Direct--

Via News Direct

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.